Alamar Biosciences (ALMR) stock
ALMR's Quality Score fell 1 point on Mon, Oct 26, to 0. Closed away from the day's high (2 chart checks stopped).
New listing, trading since Apr 17, 2026. 133 trading days so far, so 2 of the 14 chart checks wait for more history.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Key facts on ALMR
| Holding it back | Moves 8.7% a day with no profit behind it |
| Latest filing | 10-Q, Aug 11 |
1 more reason behind ALMR's 0, for Pro members.
What's next
Sat Apr 17: One year since its IPOListed Apr 17, 2026 at $17.
ALMR catalysts
After its last 2 reports it closed +16.0% on average, higher 2 of 2 times.
Why ALMR scores 0
Below AverageTrending down, 3 of 14 chart checks firingWhat the Quality Score means
- +3Chart checks 3 of 14 firing right now, one point each
- −2Volatility moves 8.7% a day with no profit or positive free cash flow over four quarters on file
- Insider trades subtracts
Here is what Pro members see.
- Prices refresh every 2.5 seconds during market hours.
- Optional alerts by push, email, or the bell.
- Add it to your Home Screen and it opens like an app.
ALMR has 3 of 14 chart checks firing
ALMR RSI today: 52.4, below its 50-day average
- RSI 1452.4
- MACD (12, 26, 9)Above signal
- 50-day average$30.74
- ADX 1423.9
- Support$27.25
- Resistance$37.76
- High since listing$39.61
- Low since listing$18.84
- Chart patternNone
- Bollinger Bands (20, 2)Inside
- Volume0.8x
The deep dive on ALMR
- What it does and how it makes money
- Where it stands
- Who holds and trades itForm 4, filed Oct 19, 2026
How ALMR ranks in Life Science Tools
ALMR is #14 of 15 by Quality Score among Laboratory Analytical Instruments.
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 14 |
When does ALMR report earnings, and what happens after?
Reports Tue Nov 3, after the close (in 8 days). Confirmed.
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
What ALMR reported on Aug 10, 2026
The quarter
The figures are not read from the release yet.
“Consumable revenue grew 147% to $15.5 million, from $6.3 million for the corresponding prior-year period, driven primarily by strong demand for multiplex panels.”
Where the sales came from
ALMR's results filing gives no sales by line in a table we read.
The outlook
| Measure | Figure |
|---|---|
| Revenue | $116M to $120M |
In the company's words
“The increase in gross margin was primarily driven by manufacturing efficiencies for consumables and a favorable shift in mix toward high-margin consumables.”
From its results filing (SEC filing · Aug 10)
The numbers
- $2.1B
- today
| Reported | Gap | Reaction | 5 sessions |
|---|---|---|---|
| Aug 10, 2026 | +3.6% | +30.6% | +14.8% |
| May 8, 2026 | -2.3% | +1.3% | -4.9% |
Who is trading ALMR
ALMR insider trades
One insider sold $21M across 52 filings in the last 6 months. No open-market buys on record. The newest:
ALMR's officers and directors
Officers and directors with a Form 4 in the last 12 months.
Which ETFs hold ALMR?
In ETFs: ALMR is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.
About Alamar Biosciences
Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.
Listed on Nasdaq on Apr 17, 2026, and is 79% above its $17 offer price now. Its IPO filing and first days
ALMR's score card
Pro members see every line of every stock's score.
- What would turn ALMR's score around: 4 things
- Real-time prices, no delay
- Every line of ALMR's score, with the points and the reason
Straight Answers
Is ALMR a good stock to buy? What its Quality Score says
ALMR scores 0 today, which Breakaway calls Below Average. It is #14 of 15 in Laboratory Analytical Instruments by Quality Score, with 3 of 14 chart checks firing. Shares: 5.1 times the count a year ago (to Jun 30). Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
What is ALMR's Quality Score?
ALMR scores 0 today, which Breakaway calls Below Average (0 to 5). That is #14 of 15 in Laboratory Analytical Instruments by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind ALMR's 0.
Are insiders buying ALMR?
One insider sold $21M across 52 filings in the last 6 months. No open-market buys on record. The newest is Qiming Corporate GP VI, LTD., 10% owner, who sold $2.7M on Oct 21. Every filing, with the scored weight, for Pro members.
Are the prices delayed?
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.